Difference between revisions of "Team:Sydney Australia/Design"

Line 295: Line 295:
 
</figure>
 
</figure>
 
<figure class="snip1507">
 
<figure class="snip1507">
   <div class="profile-image"><img src="https://static.igem.org/mediawiki/2017/4/4c/T--Sydney_Australia--PDSingleStrand.gif"/>
+
   <div class="profile-image"><img class = "crispy" src="https://static.igem.org/mediawiki/2017/4/4c/T--Sydney_Australia--PDSingleStrand.gif"/>
 
   </div>
 
   </div>
 
   <figcaption>
 
   <figcaption>
Line 303: Line 303:
 
</figure>
 
</figure>
 
<figure class="snip1508">
 
<figure class="snip1508">
   <div class="profile-image"><img src="https://static.igem.org/mediawiki/2017/a/a0/T--Sydney_Australia--PDMoney.gif"/>
+
   <div class="profile-image"><img class = "crispy" src="https://static.igem.org/mediawiki/2017/a/a0/T--Sydney_Australia--PDMoney.gif"/>
 
   </div>
 
   </div>
 
   <figcaption>
 
   <figcaption>
Line 311: Line 311:
 
</figure>
 
</figure>
 
<figure class="snip1509">
 
<figure class="snip1509">
   <div class="profile-image"><img src="https://static.igem.org/mediawiki/2017/0/06/T--Sydney_Australia--PDWeighs.gif"/>
+
   <div class="profile-image"><img class = "crispy" src="https://static.igem.org/mediawiki/2017/0/06/T--Sydney_Australia--PDWeighs.gif"/>
 
   </div>
 
   </div>
 
   <figcaption>
 
   <figcaption>
Line 319: Line 319:
 
</figure>
 
</figure>
 
<figure class="snip1510">
 
<figure class="snip1510">
   <div class="profile-image"><img src="https://static.igem.org/mediawiki/2017/2/22/T--Sydney_Australia--PDSafety.gif"/>
+
   <div class="profile-image"><img class = "crispy"  src="https://static.igem.org/mediawiki/2017/2/22/T--Sydney_Australia--PDSafety.gif"/>
 
   </div>
 
   </div>
 
   <figcaption>
 
   <figcaption>

Revision as of 09:43, 5 October 2017

The aim of the USYD iGEM 2017 team was to address the problem of insulin inaccessibility. The design of our insulin, and its means of expression, needed to look at five key characteristics:

Stabiliy

Single Chain

Cost Effective

Intellectual Property

Safety and Efficacy